Search Results for: us stem cell

A great day for stem cell research: more on SCOTUS & details on BioTime news

Today the Supreme Court announced it would not hear the Sherley v Sebelius case, ending the court battle that has left embryonic stem cell research (ESCR) in what I’ve called a “big chill”. This is great news. It is all over the mainstream media. Even the rampant anti-science, pro-lifers have declared defeat. I’m not going

A great day for stem cell research: more on SCOTUS & details on BioTime news Read More »

Knoepfler Lab Stem Cell Person of the Year Award 2012 change: nominations must be submitted by tomorrow, Dec. 13

I’ve received such a huge response (more than 20 nominees) for the Knoepfler Lab Stem Cell Person of the Year Award and the nominees to date are so awesome that I’ve decided for practical purposes to end the nomination period a bit earlier than originally planned. Thus, tomorrow Dec. 13 will be the last day

Knoepfler Lab Stem Cell Person of the Year Award 2012 change: nominations must be submitted by tomorrow, Dec. 13 Read More »

8 simple reasons not to get unproven stem cell treatments: #3, exclusion from future clinical trials

stem-cell-treatments-e1468351591167

What’s the big deal about unproven stem cell treatments, patients often ask me. Why should patients avoid these? Because paradoxically such treatments, intended to cure disease, can have devastating negative consequences for your health. I’m doing an eight-part series, “Eight simple reasons not to get a stem cell treatment”. The first two blog posts were

8 simple reasons not to get unproven stem cell treatments: #3, exclusion from future clinical trials Read More »

WSCS2012: outstanding panel discussion on legal challenges to stem cell research

It was near to a stem cell wonk’s heaven to be in the audience for a panel discussion, entitled Understanding the Legal and Policy Challenges to Stem Cell Research, here at the World Stem Cell summit in Florida late this afternoon. The stellar panel included Jeanne Loring of Scripps, Beth Roxland of Hofstra University and formerly of

WSCS2012: outstanding panel discussion on legal challenges to stem cell research Read More »

Contentious but wonderful WSCS panel on The Role of States in Regulating Stem Cell Therapies

I’m here at the World Stem Cell Summit in Florida. I just was in the audience for a great panel discussion on The Role of States in Regulating Stem Cell Therapies. It was contentious but raised almost all of the key questions in this area. There was particularly interesting and vigorous debate between two participants,

Contentious but wonderful WSCS panel on The Role of States in Regulating Stem Cell Therapies Read More »

Intriguing interview with Robin Young, Organizer of Houston Stem Cell Summit

Next month will be the 1st Houston Stem Cell Summit organized by Robin Young, who also organizes the New York Stem Cell Summit. I’ve been a bit tough on this meeting for a perceived lack of diversity in their program of speakers. I interviewed Robin Young (RY) about the meeting and found his answers quite interesting

Intriguing interview with Robin Young, Organizer of Houston Stem Cell Summit Read More »

As stem cell industry explodes, can a static FDA keep up?

There are legitimate arguments about the degree to which the FDA should regulate stem cell clinics and the point-of-care, for-profit stem cell industry. I’ve held debates about that on my blog with argument on both sides including a very valuable debate between Dr. Chris Centeno and Doug Sipp. However, increasingly it is looking like the

As stem cell industry explodes, can a static FDA keep up? Read More »

Houston stem cell meeting lacks diversity & risks falling to groupthink

Next month there is going to be a new stem cell meeting taking place. The 1st Annual Houston Stem Cell Summit. The primary sponsor is Celltex. I’d encourage everyone to go, but I’m not so sure it’d be worth it. Why? I’m always glad to see another stem cell meeting and this one is surely unique in

Houston stem cell meeting lacks diversity & risks falling to groupthink Read More »